Healthcare stock downgraded to ‘hold’
The Investment Reporter •2018-05-30 •
Cardinal Health’s problems with Cordis, plus the negative impact of generic drug pricing on company profits, has given us pause on this healthcare stock. We recommend that purchases be deferred Read More